Gastroenterology CME Courses

Gastroenterology CME Courses

Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video, PDF, Online Download, Interactive Online
Price: Free
Release Date: October 19, 2017
Expiration Date: October 19, 2019
Summary:

Colorectal cancer (CRC) is the third-leading cause of cancer deaths in the U.S. While a majority of patients are diagnosed before their disease has metastasized, a fifth of patients have advanced disease at the time of diagnosis. Early detection and screening have been shown to significantly reduce CRC mortality, and screening is widely recommended for average-risk adults beginning at age 50 years, (as well as earlier for individuals at higher risk). Since the mid-1990s, the U.S. Preventive Services Task Force, American Cancer Society, and other groups have recommended several modalities for screening: fecal occult blood testing (FOBT), flexible sigmoidoscopy, colonoscopy, and barium enema. Recent years have seen the addition of newer screening technologies, including stool DNA, computed tomographic colonography, and capsule endoscopy.

By the end of the session the participant will be able to:

  • Describe present the current practice guideline recommendations with respect to colorectal cancer screening, including colonoscopy preparation, and apply them to patient cases
  • Identify the treatment modalities currently available for management of mCRC and apply them to patient cases using evidence-based medicine
  • Evaluate a treatment plan for a specific patient with mCRC to optimize safety, efficacy, and tolerability, suggesting modifications for improvement
  • Describe the challenges and barriers to care associated with treating patients with mCRC
Credits: 1 (AMA PRA Category 1)
Format: Interactive Online
Price: Free
Expiration Date: 6/14/18
Summary:

Speakers:

Matthew H. Kulke, MD, MMSc, Associate Professor of Medicine, Director of the Neuroendocrine and Carcinoid Tumor Program at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School

David C. Metz, MBBCh, is Professor of Medicine at the Perelman School of Medicine (University of Pennsylvania)

Topic and Learning Objectives

  • To incorporate evidence-based practices into the management of carcinoid syndrome
  • Review the efficacy and safety of treatment programs for carcinoid syndrome
  • To summarize the causes of carcinoid syndrome
  • Review the differential diagnosis and appropriate workup for the presenting symptoms

This activity is intended for US-based medical oncologists, endocrinologists and gastroenterologists, as well as oncology physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of carcinoid tumors and carcinoid syndrome. Considering the symptoms and potential complications involved in carcinoid syndrome, clinicians in cardiology, dermatology, pulmonary medicine, surgery, radiology (including interventional, diagnostic, and nuclear medicine), internal medicine and primary care may also benefit from education.

Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video, Online Download
Price: Free
Release Date: October 02, 2017
Expiration Date: October 02, 2019
Summary:

By the end of the session the participant will be able to:

  • Describe the pathophysiology of chronic idiopathic constipation
  • Describe the benefits and risks of pharmacotherapy for chronic idiopathic constipation and take them into account when formulating a treatment plan for different patients
  • Formulate an evidence-based treatment plan for a variety of patients with chronic idiopathic constipation.
  • Recommend therapy changes in patients with chronic idiopathic constipation who do not respond to a previously prescribed treatment

Target Audience: Gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with chronic idiopathic constipation

Credits: 0.25 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: January 30, 2018
Expiration Date: January 30, 2019
Summary:

Clostridium difficile (C. difficile) is a significant cause of infectious disease deaths in the United States, constituting a serious public health burden. According to the Centers for Disease Control and Prevention, nearly 250,000 people become infected with C. difficile during hospital stays each year, surpassing the number of methicillin-resistant Staphylococcus aureus infections. 

Upon successful completion of this activity, participants should be better able to:

  • Apply current evidence-based guidelines for the overall management of C. difficile infection.
  • Incorporate treatment strategies that may reduce C. difficile infection recurrence, as well as antibiotic resistance.

Share This